HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Photoreactive 111In-cyclodextrin inclusion complex: a new heterobifunctional reagent for antibody labeling.

Abstract
The compound of interest, N-5-azido-2-nitrobenzoylaminomethyl-111In-acetylacetone-alpha-cycl odextrin (CD) (V) was synthesized by the selective tosylation of alpha-CD to form 6-tosyl-6-deoxy-CD, which was then reacted with NaN3 to form 6-azido-6-deoxy-CD (II). This was followed by catalytic hydrogenation to yield III. Compound III and 111In-acetylacetone were mixed to form an inclusion complex, which was then reacted with N-5-azido-2-nitrobenzoyloxysuccinimide to yield compound V. Anti-melanoma MAbTP41.2 was added to compound V, followed by immediate photoreactivation labeling by u.v. light at 320 nm. The final product VI was purified from a Sephadex G-50 column. 111In-DTPA-MAbTP41.2 was also prepared as a control. Immunoreactivity via the cell-binding assay of VI was 87%, compared with 57% by the BADTPA method. Biodistribution in non-tumor rats yielded a liver concentration in %ID/g of 3.5, 1.7 and 1.0 for compound VI, compared to the 5.5, 5.2 and 3.1 for the BADTPA compound, at 4, 24 and 48 h post-injection, respectively.
AuthorsT S Wang, R A Fawwaz, R L Van Heertum
JournalInternational journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology (Int J Rad Appl Instrum B) Vol. 19 Issue 8 Pg. 897-902 (Nov 1992) ISSN: 0883-2897 [Print] England
PMID1428916 (Publication Type: Journal Article)
Chemical References
  • Affinity Labels
  • Antibodies, Monoclonal
  • Cyclodextrins
  • Indium Radioisotopes
Topics
  • Affinity Labels
  • Animals
  • Antibodies, Monoclonal
  • Cyclodextrins (chemical synthesis, metabolism)
  • Drug Stability
  • Indium Radioisotopes
  • Rats
  • Rats, Inbred Lew

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: